Literature DB >> 23995567

Risk factors for bleeding esophagogastric varices.

Hiroshi Yoshida1, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Junji Ueda, Eiji Uchida.   

Abstract

Bleeding from gastric varices (GVs) is generally considered more severe than that from esophageal varices (EVs) but occurs less frequently. We review the risk factors for bleeding EVs and GVs. GVs were divided into 2 groups: cardiac varices (CVs, Lg-c) and fundal varices (FVs), i.e., varices involving the fundus alone (Lg-f) or varices involving both the cardia and fundus (Lg-cf). Elevated pressure in the portal vein is a risk factor for bleeding EVs. The portal pressure in patients with GVs and a gastrorenal shunt is lower than that in patients with EVs. The large size of varices is a risk factor for bleeding EVs. Red color signs are elevated red areas that are important for predicting the risk of variceal bleeding, and red wale markings, dilated venules oriented longitudinally on the mucosal surface, have been considered to be the sign with the highest risk. Red color signs are rare in FVs, possibly because of the pronounced thickness of the mucosal layer. Bleeding EVs are not associated with use of antiulcer drugs or nonsteroidal anti-inflammatory drugs (NSAIDs). Although, in patients with bleeding GVs, "occasional" use of an oral NSAID is an important step leading to variceal hemorrhage, especially from FVs, even if the mucosa is protected by antiulcer drugs. Constipation, vomiting, severe coughing, and excessive consumption of alcohol may precipitate rupture of EVs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995567     DOI: 10.1272/jnms.80.252

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  4 in total

Review 1.  Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis.

Authors:  Jonathan K Park; Sammy Saab; Stephen T Kee; Ronald W Busuttil; Hyun J Kim; Francsico Durazo; Sung-Ki Cho; Edward Wolfgang Lee
Journal:  Dig Dis Sci       Date:  2014-12-18       Impact factor: 3.199

2.  Presence of columnar-lined esophagus is negatively associated with the presence of esophageal varices in Japanese alcoholic men.

Authors:  Akira Yokoyama; Kenro Hirata; Rieko Nakamura; Tai Omori; Takeshi Mizukami; Junko Aida; Katsuya Maruyama; Tetsuji Yokoyama
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

3.  Clinical characteristics and predictors of esophagogastric variceal bleeding among patients with HCV-induced liver cirrhosis: An observational comparative study.

Authors:  Saad El Deen Mohamed El Sheref; Shimaa Afify; Mahmoud S Berengy
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

4.  Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial.

Authors:  Talles Bazeia Lima; Lívia Alves Amaral Santos; Hélio Rubens de Carvalho Nunes; Giovanni Faria Silva; Carlos Antonio Caramori; Xingshun Qi; Fernando Gomes Romeiro
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.